Store launching soon — browse the catalog and join the waitlist to be notified at launch.
✦USPS Priority Mail1–3 day delivery across the U.S.Free on orders over $200
Store launching soon — browse the catalog and join the waitlist to be notified at launch.
Your cart is empty
Angiotensin IV Analogue — Nasal Spray
Also known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide
Dihexa is a synthetic angiotensin IV–derived peptidomimetic studied in research for procognitive and synaptogenic activity.
🚀 Launching soon — join the waitlist to be notified when this product is available.
This product is intended strictly for laboratory research use within the United States. It is not approved by the FDA for the diagnosis, treatment, cure, or prevention of any disease. Not for human or veterinary use.
By purchasing, you confirm the material will be used solely for lawful research purposes in accordance with applicable U.S. federal, state, and local regulations.
Dihexa is a synthetic angiotensin IV–derived peptidomimetic studied in research for procognitive and synaptogenic activity.
Experimental models examine its interaction with the hepatocyte growth factor (HGF)/c-Met system under controlled laboratory conditions.
Third-party tested for purity, ID, quantity.
Dihexa is a small-molecule analogue derived from angiotensin IV, characterized in research for its synaptogenic effects and metabolic stability relative to the parent peptide. Investigations have focused on its dependence on the HGF/c-Met receptor system for procognitive activity.
Preclinical studies have evaluated synapse formation and cognitive-model endpoints under structured conditions.
Dihexa emerged from structure–activity research on angiotensin IV analogues aimed at producing metabolically stable, blood–brain-barrier-penetrant compounds for neurodegeneration research.
Work at the angiotensin IV/HGF interface established its synaptogenic profile in laboratory models.
Research into dihexa focuses on synaptogenesis and the HGF/c-Met signaling system. Frameworks evaluate angiotensin IV analogue pharmacology and cognitive-model endpoints under controlled preclinical conditions.
No. Eppix Labs products are supplied exclusively for laboratory research. We do not provide dosing, administration, or usage guidance.
Each unit contains the labeled quantity of dihexa. Independent third-party analysis verifies purity, identity, and net content per batch.
The unit contains only the research compound. Any laboratory materials required for reconstitution or experimental procedures must be sourced separately.
Duration depends entirely on research design, storage conditions, and laboratory protocol.
The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system
PubMedThe Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease
PubMedThe development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases
PubMedRelated
Pentadecapeptide studied for angiogenesis signaling, tissue repair pathways, and cellular regeneration research
From$50.00
$60.00
Small molecule studied for metabolic regulation, NAD pathways, and cellular energy signaling
From$40.00
Dual peptide complex studied for actin signaling, tissue regeneration pathways, and recovery system research
From$80.00
Oral peptide format studied for systemic repair signaling and gastrointestinal pathway research
$140.00
